Kiwi Biosciences Analysis: $130K Raised
What is Kiwi Biosciences?
Kiwi Biosciences develops FODZYME®, an enzyme blend that aids digestion of high FODMAP foods, enabling comfortable meal enjoyment for individuals.
Employees
10
Founded
2020
Revenue
$1.2M
Company Stage
Seed
YC Batch
S21
Product Features & Capabilities
- FODZYME® enzyme blend, home kit, on-the-go kit, anywhere bundle, aids in digestion of foods high in FODMAPs, allows enjoyment of meals without discomfort.
How much Kiwi Biosciences raised
1 - $0.13M
2020Lead Investor: Y Combinator, North South Ventures
Who are the founders of Kiwi Biosciences
AL
Anjie Liu
Founder
DH
David Hachuel Gurska
Founder
Company Pricing
- Home Kit: From $65.00
- On-the-Go Kit: From $65.00
- Anywhere Bundle: From $119.00
Investors
- Acacia Venture Capital Partners
- Jude Gomila
- Emily Leproust
- (Additional investors not specified)
